Semaglutide Shows No Significant Effect in Alzheimer’s Trials
Effect – The results from the highly anticipated Evoke Phase 3 clinical trials evaluating oral semaglutide as a potential treatment for Alzheimer’s disease have brought a mix of clarity and disappointment to the scientific community.,…
